Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT00493298 ×

NCT00493298

This funder is selected. Its supporting articles are shown below.

NCT004932981

Articles mentioning NCT00493298

1 articles · page 1 of 1

Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 years

jnnp · abstract · 2026-06-12 · 1 matching annotations

86.0%

NCT00493298 natalizumab natalizumab-associated RRMS relapsing-remitting multiple sclerosis TOP SPMS

…real-world effectiveness of natalizumab in patients with RRMS ( NCT00493298).…